The prion protein and its ligands: Insights into structure-function relationships.

Amyloid proteins Neurodegeneration PrP(C) PrP(C) ligands PrP(C) mediated signal transduction Prion protein Protein aggregation Protein misfolding Proteolytic cleavages of cellular prion protein shed PrP

Journal

Biochimica et biophysica acta. Molecular cell research
ISSN: 1879-2596
Titre abrégé: Biochim Biophys Acta Mol Cell Res
Pays: Netherlands
ID NLM: 101731731

Informations de publication

Date de publication:
06 2022
Historique:
received: 08 10 2021
revised: 23 01 2022
accepted: 28 01 2022
pubmed: 23 2 2022
medline: 19 4 2022
entrez: 22 2 2022
Statut: ppublish

Résumé

The prion protein is a multifunctional protein that exists in at least two different folding states. It is subject to diverse proteolytic processing steps that lead to prion protein fragments some of which are membrane-bound whereas others are soluble. A multitude of ligands bind to the prion protein and besides proteinaceous binding partners, interaction with metal ions and nucleic acids occurs. Although of great importance, information on structural and functional consequences of prion protein binding to its partners is limited. Here, we will reflect on the structure-function relationship of the prion protein and its binding partners considering the different folding states and prion protein fragments.

Identifiants

pubmed: 35192891
pii: S0167-4889(22)00031-3
doi: 10.1016/j.bbamcr.2022.119240
pii:
doi:

Substances chimiques

Ligands 0
Prion Proteins 0
Prions 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

119240

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Mohsin Shafiq (M)

Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20251 Hamburg, Germany.

Stefano Da Vela (S)

European Molecular Biology Laboratory (EMBL), Hamburg c/o German Electron Synchrotron (DESY), Notkestraße 85, 22607 Hamburg, Germany.

Ladan Amin (L)

Department of Biochemistry, Boston University School of Medicine, Boston, MA, United States.

Neelam Younas (N)

Department of Neurology, University Medical Center Goettingen, Robert-Koch-str. 40, 37075 Goettingen, Germany.

David A Harris (DA)

Department of Biochemistry, Boston University School of Medicine, Boston, MA, United States.

Inga Zerr (I)

Department of Neurology, University Medical Center Goettingen, Robert-Koch-str. 40, 37075 Goettingen, Germany.

Hermann C Altmeppen (HC)

Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20251 Hamburg, Germany.

Dmitri Svergun (D)

European Molecular Biology Laboratory (EMBL), Hamburg c/o German Electron Synchrotron (DESY), Notkestraße 85, 22607 Hamburg, Germany.

Markus Glatzel (M)

Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20251 Hamburg, Germany. Electronic address: m.glatzel@uke.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH